Daniel R. Hart - 10 Jul 2023 Form 4 Insider Report for Avid Bioservices, Inc.

Role
Chief Financial Officer
Signature
/s/ Daniel R. Hart
Issuer symbol
N/A
Transactions as of
10 Jul 2023
Net transactions value
-$52,153
Form type
4
Filing time
12 Jul 2023, 19:37:17 UTC
Previous filing
11 Jul 2023
Next filing
11 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +10,723 +17% 75,143 10 Jul 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale $52,153 -3,763 -5% $13.86 71,380 11 Jul 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -4,856 -5.6% $0.000000 82,013 10 Jul 2023 Common Stock 4,856 Direct F1, F4
transaction CDMO Restricted Stock Units Options Exercise $0 -5,867 -7.2% $0.000000 76,146 10 Jul 2023 Common Stock 5,867 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4 and 5. This sale does not represent a discretionary trade by the reporting person.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $13.77 to $13.86. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 RSUs granted to the reporting person on July 10, 2020, vest in four (4) equal annual installments beginning July 10, 2021, and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F5 RSUs granted to the reporting person on July 10, 2019, vested in four (4) equal annual installments and was fully-vested as of July 10, 2023.